Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inhibition of phospholipase C-gamma 1 augments the decrease in cardiomyocyte viability by H2O2.

Rabban Mangat1, Tushi Singal, Naranjan S Dhalla

  • 1Department of Human Nutritional Sciences, Faculty of Human Ecology, University of Manitoba, and Institute of Cardiovascular Sciences, St. Boniface Hospital Research Centre, Winnipeg, Canada.

American Journal of Physiology. Heart and Circulatory Physiology
|February 28, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathophysiology and pharmacotherapy of cardiovascular complications in metabolic syndrome.

Journal of molecular and cellular cardiology·2026
Same author

Metabolic therapy for cardiovascular diseases with propionyl L-carnitine.

Canadian journal of physiology and pharmacology·2026
Same author

Improvement of Cardiac Function by Polyclonal Antibodies Against Ca<sup>2+</sup>/Mg<sup>2+</sup> ecto-ATPase in Hearts Subjected to Ischemia-Reperfusion.

International journal of molecular sciences·2026
Same author

Translational impact of machine learning-driven predictive modeling with pathway-based plasma metabolomic biomarkers for lung cancer detection.

Frontiers in oncology·2026
Same author

Special Issue "Molecular Insights into the Developmental Origins of Health and Disease".

International journal of molecular sciences·2025
Same author

High fructose consumption induces cardiac dysfunction and vascular abnormalities.

Canadian journal of physiology and pharmacology·2025

Phospholipase C (PLC) gamma 1 activation protects cardiomyocytes from oxidative stress via protein kinase C-epsilon (PKC-epsilon) and Bcl-2 phosphorylation. This pathway enhances cardiac cell survival during oxidative damage.

Area of Science:

  • Cardiovascular Biology
  • Cellular Signaling
  • Oxidative Stress Research

Background:

  • Oxidative stress poses a significant threat to cardiomyocyte function and survival.
  • Phospholipase C (PLC) isozymes play critical roles in cellular signaling pathways.
  • The specific role of PLC-gamma 1 in cardiomyocytes under oxidative stress remains to be fully elucidated.

Purpose of the Study:

  • To investigate the involvement of cardiac phospholipase C (PLC) gamma 1 in cardiomyocytes during oxidative stress.
  • To determine the signaling pathways downstream of PLC-gamma 1 activation in response to hydrogen peroxide (H2O2).
  • To assess the impact of PLC-gamma 1 activity on cardiomyocyte viability and apoptosis.

Main Methods:

  • Isolation and treatment of adult rat left ventricular cardiomyocytes with varying concentrations of H2O2.

Related Experiment Videos

  • Quantification of PLC-gamma 1 mRNA and protein levels via Western blotting and RT-PCR.
  • Assessment of PLC-gamma 1 activation through tyrosine residue phosphorylation.
  • Analysis of protein kinase C (PKC)-delta and -epsilon activation and phosphorylation.
  • Evaluation of Bcl-2 phosphorylation and its modulation by PLC and PKC inhibitors.
  • Measurement of cardiomyocyte viability using trypan blue exclusion and assessment of apoptosis.
  • Main Results:

    • H2O2 treatment induced a concentration-dependent increase in PLC-gamma 1 mRNA and protein levels, along with its activation.
    • PLC-gamma 1 activation led to increased phosphorylation of the antiapoptotic protein Bcl-2.
    • PKC-epsilon activation, but not PKC-delta, was dependent on PLC activity and contributed to Bcl-2 phosphorylation.
    • Inhibition of PKC-epsilon exacerbated H2O2-induced cardiomyocyte death and apoptosis.
    • Pharmacological inhibition of PLC also resulted in decreased cardiomyocyte viability and increased apoptosis.

    Conclusions:

    • PLC-gamma 1 plays a crucial role in protecting cardiomyocytes against oxidative stress.
    • The protective mechanism involves the activation of PKC-epsilon, leading to Bcl-2 phosphorylation.
    • Targeting the PLC-gamma 1/PKC-epsilon/Bcl-2 pathway may offer therapeutic strategies for conditions involving cardiac oxidative damage.